Skip to content
Menu
GammaTile Therapy
Elevating Outcomes
Advancing Safety
How It Works
Clinical Resources
Roads
Gestalt
GammaTile Centers
Recruiting Trials
Tumor Bed Calculator
News
Events
Contact
Blog
The US Food and Drug Administration Provides Notice of 510(k) Clearance of GammaTile Therapy in the Treatment of Recurrent Intracranial Neoplasms
You may also like:
News Articles
What’s Happening in Health: Liz Bonis is Joined by a Team to Talk About Brain Tumor Surgery
November 10, 2019
News Articles
Westchester Medical Center First in Region to Offer Brain Tumor Therapy That Can Slow Tumor Progression
July 15, 2021
News Articles
Vidant, ECU Brody School of Medicine Successfully Perform First-in-State GammaTile Procedure
January 22, 2020
We use cookies to enhance your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
Accept
Privacy policy
